vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Quest Resource Holding Corp（QRHC）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Quest Resource Holding Corp的1.3倍（$75.5M vs $58.9M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -15.8%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $1.0M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -10.0%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Quest Resource Holding Corp是北美地区的可持续发展及废弃物管理服务提供商，面向商业、工业及零售客户提供一体化废弃物回收、资源化利用解决方案，帮助企业减少废弃物排放、降低运营成本，达成既定环保目标。
PBYI vs QRHC — 直观对比
营收规模更大
PBYI
是对方的1.3倍
$58.9M
营收增速更快
PBYI
高出43.5%
-15.8%
自由现金流更多
PBYI
多$13.4M
$1.0M
两年增速更快
PBYI
近两年复合增速
-10.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $58.9M |
| 净利润 | — | $-1.7M |
| 毛利率 | 69.3% | 15.5% |
| 营业利润率 | 22.7% | 0.9% |
| 净利率 | — | -2.8% |
| 营收同比 | 27.7% | -15.8% |
| 净利润同比 | — | 82.6% |
| 每股收益（稀释后） | $0.26 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIQRHC
| Q4 25 | $75.5M | $58.9M | ||
| Q3 25 | $54.5M | $63.3M | ||
| Q2 25 | $52.4M | $59.5M | ||
| Q1 25 | $46.0M | $68.4M | ||
| Q4 24 | $59.1M | $70.0M | ||
| Q3 24 | $80.5M | $72.8M | ||
| Q2 24 | $47.1M | $73.1M | ||
| Q1 24 | $43.8M | $72.7M |
净利润PBYIQRHC
| Q4 25 | — | $-1.7M | ||
| Q3 25 | $8.8M | $-1.3M | ||
| Q2 25 | $5.9M | $-2.0M | ||
| Q1 25 | $3.0M | $-10.4M | ||
| Q4 24 | — | $-9.5M | ||
| Q3 24 | $20.3M | $-3.4M | ||
| Q2 24 | $-4.5M | $-1.5M | ||
| Q1 24 | $-4.8M | $-655.0K |
毛利率PBYIQRHC
| Q4 25 | 69.3% | 15.5% | ||
| Q3 25 | 77.7% | 18.1% | ||
| Q2 25 | 76.5% | 18.5% | ||
| Q1 25 | 77.1% | 16.0% | ||
| Q4 24 | 76.4% | 15.3% | ||
| Q3 24 | 63.9% | 16.1% | ||
| Q2 24 | 77.4% | 18.5% | ||
| Q1 24 | 75.5% | 19.3% |
营业利润率PBYIQRHC
| Q4 25 | 22.7% | 0.9% | ||
| Q3 25 | 17.6% | 1.7% | ||
| Q2 25 | 12.7% | 0.6% | ||
| Q1 25 | 8.7% | -11.9% | ||
| Q4 24 | 22.6% | -10.3% | ||
| Q3 24 | 27.4% | -1.3% | ||
| Q2 24 | -4.6% | 2.4% | ||
| Q1 24 | -5.3% | 2.6% |
净利率PBYIQRHC
| Q4 25 | — | -2.8% | ||
| Q3 25 | 16.2% | -2.1% | ||
| Q2 25 | 11.2% | -3.3% | ||
| Q1 25 | 6.5% | -15.2% | ||
| Q4 24 | — | -13.6% | ||
| Q3 24 | 25.2% | -4.7% | ||
| Q2 24 | -9.6% | -2.1% | ||
| Q1 24 | -11.0% | -0.9% |
每股收益（稀释后）PBYIQRHC
| Q4 25 | $0.26 | $-0.08 | ||
| Q3 25 | $0.17 | $-0.06 | ||
| Q2 25 | $0.12 | $-0.09 | ||
| Q1 25 | $0.06 | $-0.50 | ||
| Q4 24 | $0.40 | $-0.47 | ||
| Q3 24 | $0.41 | $-0.16 | ||
| Q2 24 | $-0.09 | $-0.07 | ||
| Q1 24 | $-0.10 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $1.0M |
| 总债务越低越好 | $22.7M | $64.0M |
| 股东权益账面价值 | $130.3M | $40.5M |
| 总资产 | $216.3M | $145.6M |
| 负债/权益比越低杠杆越低 | 0.17× | 1.58× |
8季度趋势，按日历期对齐
现金及短期投资PBYIQRHC
| Q4 25 | $97.5M | $1.0M | ||
| Q3 25 | $94.4M | $1.1M | ||
| Q2 25 | $96.0M | $449.0K | ||
| Q1 25 | $93.2M | $1.4M | ||
| Q4 24 | $101.0M | $396.0K | ||
| Q3 24 | $96.7M | $1.1M | ||
| Q2 24 | $96.8M | $957.5K | ||
| Q1 24 | $107.2M | $581.1K |
总债务PBYIQRHC
| Q4 25 | $22.7M | $64.0M | ||
| Q3 25 | $34.0M | $65.4M | ||
| Q2 25 | $45.3M | $69.7M | ||
| Q1 25 | $56.7M | $74.1M | ||
| Q4 24 | $68.0M | $76.3M | ||
| Q3 24 | $79.3M | $71.9M | ||
| Q2 24 | $90.7M | $70.7M | ||
| Q1 24 | $102.0M | $68.5M |
股东权益PBYIQRHC
| Q4 25 | $130.3M | $40.5M | ||
| Q3 25 | $115.3M | $42.0M | ||
| Q2 25 | $104.7M | $42.9M | ||
| Q1 25 | $97.1M | $44.4M | ||
| Q4 24 | $92.1M | $54.2M | ||
| Q3 24 | $71.1M | $62.8M | ||
| Q2 24 | $48.5M | $65.6M | ||
| Q1 24 | $51.0M | $66.3M |
总资产PBYIQRHC
| Q4 25 | $216.3M | $145.6M | ||
| Q3 25 | $202.9M | $149.3M | ||
| Q2 25 | $194.9M | $153.1M | ||
| Q1 25 | $196.2M | $165.7M | ||
| Q4 24 | $213.3M | $175.6M | ||
| Q3 24 | $220.7M | $178.2M | ||
| Q2 24 | $205.0M | $181.8M | ||
| Q1 24 | $214.1M | $179.0M |
负债/权益比PBYIQRHC
| Q4 25 | 0.17× | 1.58× | ||
| Q3 25 | 0.30× | 1.56× | ||
| Q2 25 | 0.43× | 1.62× | ||
| Q1 25 | 0.58× | 1.67× | ||
| Q4 24 | 0.74× | 1.41× | ||
| Q3 24 | 1.12× | 1.15× | ||
| Q2 24 | 1.87× | 1.08× | ||
| Q1 24 | 2.00× | 1.03× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $1.1M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $1.0M |
| 自由现金流率自由现金流/营收 | 19.1% | 1.7% |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $9.3M |
8季度趋势，按日历期对齐
经营现金流PBYIQRHC
| Q4 25 | $14.4M | $1.1M | ||
| Q3 25 | $9.7M | $5.7M | ||
| Q2 25 | $14.1M | $3.9M | ||
| Q1 25 | $3.6M | $-1.1M | ||
| Q4 24 | $15.6M | $-4.8M | ||
| Q3 24 | $11.0M | $-475.0K | ||
| Q2 24 | $1.0M | $808.0K | ||
| Q1 24 | $11.2M | $-1.7M |
自由现金流PBYIQRHC
| Q4 25 | $14.4M | $1.0M | ||
| Q3 25 | $9.7M | $5.6M | ||
| Q2 25 | $14.1M | $3.9M | ||
| Q1 25 | $3.6M | $-1.2M | ||
| Q4 24 | $15.6M | $-5.2M | ||
| Q3 24 | $11.0M | $-583.0K | ||
| Q2 24 | $1.0M | $-1.4M | ||
| Q1 24 | — | $-3.6M |
自由现金流率PBYIQRHC
| Q4 25 | 19.1% | 1.7% | ||
| Q3 25 | 17.7% | 8.9% | ||
| Q2 25 | 26.8% | 6.5% | ||
| Q1 25 | 7.7% | -1.8% | ||
| Q4 24 | 26.4% | -7.4% | ||
| Q3 24 | 13.7% | -0.8% | ||
| Q2 24 | 2.1% | -2.0% | ||
| Q1 24 | — | -4.9% |
资本支出强度PBYIQRHC
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 0.0% | 0.6% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | 0.0% | 3.1% | ||
| Q1 24 | 0.0% | 2.6% |
现金转化率PBYIQRHC
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
QRHC
| Services | $55.8M | 95% |
| Product Sales And Other | $3.1M | 5% |
